Home
Treeline Biosciences, Inc.

Treeline Biosciences, Inc. Market Share Analysis for June 2026

Medicines in the making: introducing our first clinical programs

Industry: N/A

Domaintreeline.bio

Year Founded2021

Employees51 - 200

Annual Revenue$50M - $75M

Treeline Biosciences, Inc.

Treeline Biosciences, Inc. (including company regionals)

treeline.bio

See more website traffic and engagement information

Treeline Biosciences, Inc. Revenue up to June 2026 is 50M - 75M

revenue generated by Treeline Biosciences, Inc. top domains

Treeline Biosciences, Inc. top domains revenue over 3 years

Revenue for Treeline Biosciences, Inc. top domains

treeline.bio50M - 75M

See more with Sales Intelligence

Total visits to Treeline Biosciences, Inc.'s top domains

Understand Treeline Biosciences, Inc. market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

treeline.bio8.2K

See more with Sales Intelligence

Avg. visit duration in Treeline Biosciences, Inc.'s top domains

Analyze Treeline Biosciences, Inc. engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

treeline.bio00:02:36

See more with Sales Intelligence

Avg. pageviews on Treeline Biosciences, Inc.'s top domains

See how Treeline Biosciences, Inc. keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

treeline.bio2.71

See more with Sales Intelligence

Treeline Biosciences, Inc. top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Treeline Biosciences, Inc.

These are the website technologies, by industry, used by Treeline Biosciences, Inc. top domains

Content Management System (4)

Web Dot Com

Advertising (2)

DoubleClick

Email Services (2)

Microsoft Exchange Online

Marketing (2)

Google Marketing Platform

More Technologies

8

See all

News & Signals from Treeline Biosciences, Inc.

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsTreeline Biosciences, Inc. is planning to acquire Standard BioTools Inc..Under the terms of the Merger Agreement, Standard BioTools will be acquired by Treeline Biosciences, Inc. At the closing of the proposed combination, pre-merger Standard BioTools stockholders are expected to own approximately 16% of the combined company, and pre-merger Treeline stockholders are expected to own approximately 84% of the combined company.

NewsTreeline Biosciences, Inc. is developing Bcl-xl degraders on May 27th '26.Treeline Biosciences prepares new Bcl-xl degraders.

NewsTreeline Biosciences, Inc. receives financing of $200M in Series A1.Treeline Biosciences commences Phase 1 trials and secures $200 million Series A extension funding.